November 17, 2026 · Obstetrics and gynecology · DOI: 10.1097/AOG.0000000000006476

A Randomized Trial of Fractionated CO2 Laser With Topical Clobetasol Compared With Fractionated CO2 Laser With Placebo for Treatment of Vulvar Lichen Sclerosus.

Listen to this summary

This double-blind, randomized trial asked whether adding topical clobetasol propionate 0.05% to fractionated CO2 laser treatment improves skin-related outcomes in women with vulvar lichen sclerosus compared with laser plus placebo ointment. The primary outcome, a 16-point or greater improvement on the Skindex-29, did not differ between groups (30.3% clobetasol vs 27.5% placebo, P=.67), though the clobetasol group reported greater improvement in symptom scores, higher treatment satisfaction, and low, similar adverse event rates. Overall, the findings suggest clobetasol may add symptom relief and satisfaction to laser therapy, but it did not meet the primary efficacy endpoint.

Alexis A Dieter, Kimberly Ferrante, Akira Gillingham, Christine M Vaccaro, Meagan Simpson, Kate V Meriwether, Sarit Aschkenazi, Ladin A Yurteri-Kaplan, Lisa C Hickman, Emily Von Bargen, Silpa Nekkanti, Melissa G Goodwin, Mihriye Mete, Holly E Richter, Margaret G Mueller, Kimberly Kenton, Cara Grimes, Cheryl B Iglesia

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play